Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Controlled Antenatal Thyroid Screening study
ISRCTN ISRCTN46178175
ClinicalTrials.gov identifier
Public title Controlled Antenatal Thyroid Screening study
Scientific title Randomised controlled trial of the effect of gestational thyroid hormone intervention therapy on childhood development
Acronym CATS
Serial number at source 065143
Study hypothesis Aim is to evaluate strategy of screening of thyroid function in early pregnancy.
Lay summary Not provided at time of registration
Ethics approval Trent Multi-Centre Research Ethics Committee gave approval on the 24th June 2004 (ref: MREC/04/4/026)
Study design Multicentre, randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Childhood Development
Participants - inclusion criteria All pregnant women (aged 18 - 45 years) before 16 weeks gestation
Participants - exclusion criteria 1. Twin pregnancy
2. Thyroid treatment (T4 or antithyroid drugs)
Anticipated start date 01/06/2002
Anticipated end date 01/06/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 22,000 - recruitment closed on 31st May 2006
Interventions Please note that, as of 18 January 2007, this trial is closed to recruitment: follow up continuing

Sera obtained from pregnant women before 16 weeks gestation. Sera randomised to 'screen' (T4 and Thyroid Stimulating Hormones [TSH] measured at time of randomisation) and 'control' (hormones measured post delivery) groups. Thyroxine intervention given to screen group with low T4/high TSH and to control group postpartum.
This is the only prospective randomised intervention trial of thyroxine in early pregnancy.
Primary outcome measure(s) Intelligence Quotient (IQ) of children in screen and control groups.
Secondary outcome measure(s) No secondary outcome measures
Sources of funding The Wellcome Trust (UK) (grant ref: GRO65143MA)
Trial website
Publications
Contact name Prof  John H  Lazarus
  Address Cardiff University
University Hospital of Wales
Professor of Clinical Endocrinology/
Heath Park
  City/town Cardiff
  Zip/Postcode CF14 4XN
  Country United Kingdom
  Tel +44 (0)29 20 742193
  Fax +44 (0)29 20 742193
  Email Lazarus@cf.ac.uk
Sponsor Cardiff University (UK)
  Address McKenzie House
Physical and Financial Resources
30-36 Newport Road
PO Box 497
  City/town Cardiff
  Zip/Postcode CF10 3XR
  Country United Kingdom
  Tel +44 (0)29 2087 9255
  Email Arnoldc1@cardiff.ac.uk
  Sponsor website: http://www.cardiff.ac.uk/index.html
Date applied 22/07/2005
Last edited 12/09/2011
Date ISRCTN assigned 22/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central